Navigation Links
Auxilium Pharmaceuticals Announces Additional Data from Three-Year XIAFLEX® Recurrence Study in Dupuytren's Contracture in E-poster at ASSH Meeting
Date:9/8/2011

ents of assumption underlying or relating to any of the foregoing). Forward-looking statements can generally be identified by words such as "believe," "appears," "may," "could," "will," "estimate," "continue," "anticipate," "intend," "should," "plan," "expect," and other words and terms of similar meaning in connection with any discussion of projections, future performance or expectations, beliefs, plans or objectives for future operations (including statements of assumption underlying or relating to any of the foregoing). Actual results may differ materially from those reflected in these forward-looking statements due to various factors, including further evaluation of clinical data, results of clinical trials, decisions by regulatory authorities as to whether and when to approve drug applications, and general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industries and those discussed in Auxilium's Annual Report under the heading "Risk Factors" on Form 10-K for the year ended December 31, 2010 and Form 10-Q for the quarter ended June 30, 2011, which are on file with the Securities and Exchange Commission (the "SEC") and may be accessed electronically by means of the SEC's home page on the Internet at http://www.sec.gov or by means of Auxilium's home page on the Internet at http://www.Auxilium.com under the heading "For Investors -- SEC Filings." There may be additional risks that Auxilium does not presently know or that Auxilium currently believes are immaterial which could also cause actual results to differ from those contained in the forward-looking statements. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. Therefore, you should not rely on any such factors or forward-looking statements.

In addition, forward-looking statements provide Auxilium's expectations, plan
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Auxilium Pharmaceuticals Announces Positive Data from Commercial Patient Chart Review in E-posters at ASSH Meeting
2. Auxilium Pharmaceuticals, Inc. Announces Positive Top-Line Results from XIAFLEX® Multi-Cord Study
3. Auxilium Pharmaceuticals, Inc. and BioSpecifics Technologies Corp. Announce Plans to Develop Additional Indications using XIAFLEX®
4. Auxilium Pharmaceuticals Announces Investor Event to Occur at 2011 ASSH Meeting on September 9, 2011
5. Auxilium Pharmaceuticals to Present at the Stifel Nicolaus 2011 Healthcare Conference
6. Auxilium Pharmaceuticals, Inc. Announces Promotion of Dr. James P. Tursi to Chief Medical Officer
7. Auxilium Pharmaceuticals to Announce Second Quarter 2011 Results and Conduct Conference Call on Monday, August 1, 2011
8. Auxilium Pharmaceuticals Announces Results from Three Year CORDLESS Extension Study in Dupuytrens Contracture
9. Auxilium Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference
10. Auxilium Pharmaceuticals to Present at the Deutsche Bank 36th Annual Health Care Conference
11. Auxilium Pharmaceuticals, Inc. Announces Launch of XIAPEX® in EU by Pfizer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... March 4, 2015 XBiotech announced today ... in patients with moderate to severe plaque psoriasis ... Phase II trial evaluated the potential benefit of ... targets interleukin-1 alpha (IL-1a). IL-1a is a pro-inflammatory ... in skin lesions. The Company claims that blockade ...
(Date:3/4/2015)... Kan. , March 4, 2015   Aratana ... pet therapeutics company focused on the licensing, development and ... announced that it will present at the Barclays ... 2015, at the Loews Miami Beach Hotel in ... Steven St. Peter , M.D., President and Chief Executive ...
(Date:3/4/2015)... 4, 2015 Following the reintroduction of ... Center (LAC) released a report today urging policymakers ... and heroin epidemic through more effective use of ... "The Case for Expanding Access to Medication-Assisted Treatment ... the health, justice, and economic advantages of medication-assisted ...
Breaking Medicine Technology:XBiotech Announces Phase II Psoriasis Study Results in JAMA Dermatology 2Aratana Therapeutics to Present at the Barclays Global Healthcare Conference 2Improved Medication-Assisted Treatment Policy Could Aid Epidemic of 20 Million Americans with Untreated Addiction 2
... Wash., Feb. 22, 2011 drugstore.com, inc. (Nasdaq: ... of health, beauty, clinical skincare, and vision products, ... at the following upcoming events with the financial ... Stanley Tech Media & Telecom Conference Date: February ...
... 2011 Express Scripts, Inc. (Nasdaq: ESRX ) announced ... 2011 Citi Global Healthcare Conference on March 3, 2011 at ... NY. 2011 Barclays Capital Global Healthcare Conference on March ... in Miami, FL These presentations will also be broadcast ...
Cached Medicine Technology:drugstore.com to Present at Upcoming Financial Conferences 2
(Date:3/4/2015)... March 04, 2015 Imagine No Malaria’s 2014 ... Care2 Innovator Award , an honor given to nonprofit ... at the Nonprofit Technology Conference (NTC15) in Austin, ... United Methodist Church in Austin, was on hand for the ... Imagine No Malaria. , Imagine No Malaria was one of ...
(Date:3/4/2015)... The Asia-Pacific phthalic anhydride market is estimated ... 2019, at a CAGR of 5.9% during the ... through the TOC of Asia-Pacific Phthalic Anhydride Market ... with the help of various tables and figures., ... a derivative of phthalic acid, which is either ...
(Date:3/4/2015)... When people talk about venues being the ... across numerous genres, the Houston Rodeo will be ... during the annual livestock show and rodeo, one popular band ... activities being held at the event. The 2015 show will ... will try and get the festival its largest attendance ever. ...
(Date:3/4/2015)... The federal litigation established for Lipitor ... caused patients to develop Type 2 diabetes continues to ... South Carolina. According to court documents, the proceeding’s next ... at 10:00 a.m. In advance of the Conference, the ... report to the Court by March 19, 2015. (In ...
(Date:3/4/2015)... FDA’s New Inspection Approach:, What Your ... 24, 2015 — 1:30 p.m. – 3:00 p.m. EDT, ... four hours of an inspection whether a manufacturer’s in ... “good” list, they’ll merely ask for reassurance that they ... the “bad” list, the manufacturer must get ready to ...
Breaking Medicine News(10 mins):Health News:Imagine No Malaria Receives Care2 Innovator Award 2Health News:Imagine No Malaria Receives Care2 Innovator Award 3Health News:The Asia-Pacific Ohthalic Anhydride Market is Estimated to Reach $5,632.8 Million by 2019 - A Report by MicroMarket Monitor 2Health News:The Asia-Pacific Ohthalic Anhydride Market is Estimated to Reach $5,632.8 Million by 2019 - A Report by MicroMarket Monitor 3Health News:Cheap Houston Rodeo Tickets: Ticket Down Slashes Houston Rodeo Tickets for John Legend, Pitbull, Alan Jackson, Tim McGraw, Zac Brown Band, Fall Out Boy & Miranda Lambert 2Health News:Cheap Houston Rodeo Tickets: Ticket Down Slashes Houston Rodeo Tickets for John Legend, Pitbull, Alan Jackson, Tim McGraw, Zac Brown Band, Fall Out Boy & Miranda Lambert 3Health News:Lipitor Lawsuit News: Bernstein Liebhard LLP Comments on Scheduling of Status Conference in Federal Lipitor Litigation 2Health News:Lipitor Lawsuit News: Bernstein Liebhard LLP Comments on Scheduling of Status Conference in Federal Lipitor Litigation 3Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 2Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 3Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 4
... a leader in the,DHA omega-3 food and supplements ... be expanding its reach in the animal feed,market ... DHA,Gold(R) product with Novus International, Inc. Martek will ... of its poultry and swine feed and,enrichment products. ...
... mortality could be reduced 20% for those awaiting new ... group-incompatible heart transplants can safely be performed in infants ... death rates among infants with heart problems, say U.S. ... reported to the United Network for Organ Sharing (UNOS)from ...
... doesn,t have excess stomach acid, study finds, , , MONDAY, ... anti-reflux medications to infants, new research suggests. , The ... given anti-reflux medications, which work by lowering levels of ... four out of five infants included in the study ...
... When lean healthy young adults gained about 9 pounds, ... -- but shedding the weight restored proper functioning, according ... important because this vessel disorder, known as endothelial dysfunction, ... the effects of modest weight gain on the disorder ...
... of Premium Term, NEW YORK, Nov. 5 ... and more convenient, AXA Equitable introduced today in,approved ... Return of,Premium Term (ROP Term(SM)) life insurance on ... with Simplified Issue makes buying life,insurance easier and ...
... World-renowned heart,surgeon Dr. Rafael Espada has made history by ... Alvaro Colom, with Dr.,Espada as his running mate, won ... the country,s votes. The two will take,office January 14, ... practiced for more than 30 years,as a heart surgeon ...
Cached Medicine News:Health News:Martek Signs Exclusive Worldwide Distributorship Agreement with Novus International 2Health News:Martek Signs Exclusive Worldwide Distributorship Agreement with Novus International 3Health News:Blood-Incompatible Heart Transplants Safe for Infants 2Health News:Anti-Reflux Drugs May Be Overprescribed in Infants 2Health News:Anti-Reflux Drugs May Be Overprescribed in Infants 3Health News:Modest gain in visceral fat causes dysfunction of blood vessel lining in lean, healthy humans 2Health News:Modest gain in visceral fat causes dysfunction of blood vessel lining in lean, healthy humans 3Health News:AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 2Health News:AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 3Health News:AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 4Health News:Houston Heart Surgeon Elected Vice President of Guatemala 2
... System provides easy-to-use features, auto iris, white ... camera head construction is based on Solos ... 1-Chip Camera System, Domestic (GS 9900-NTSC) includes: ... with power cord and video cables , ...
... The 3-Chip Camera System offers 800+ ... generator, auto iris, automatic gain control, and ... , ,Complete 3-Chip Camera System for ... , (MS 1000-01) Camera Control Unit (CCU) ...
Provides a combination of concentrated cold / hot and compression for the elbow...
Provides a combination of concentrated cold / hot and compression for the neck...
Medicine Products: